- Home
- ORIC vs CHW Comparison
ORIC vs CHW Comparison
Compare ORIC & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- CHW
- Stock Information
- Founded
- ORIC 2014
- CHW 2007
- Country
- ORIC United States
- CHW United States
- Employees
- ORIC N/A
- CHW N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- CHW Investment Managers
- Sector
- ORIC Health Care
- CHW Finance
- Exchange
- ORIC Nasdaq
- CHW Nasdaq
- Market Cap
- ORIC 545.5M
- CHW 439.4M
- IPO Year
- ORIC 2020
- CHW N/A
- Fundamental
- Price
- ORIC $5.61
- CHW $6.41
- Analyst Decision
- ORIC Strong Buy
- CHW
- Analyst Count
- ORIC 9
- CHW 0
- Target Price
- ORIC $18.43
- CHW N/A
- AVG Volume (30 Days)
- ORIC 672.2K
- CHW 195.2K
- Earning Date
- ORIC 05-05-2025
- CHW 01-01-0001
- Dividend Yield
- ORIC N/A
- CHW 9.27%
- EPS Growth
- ORIC N/A
- CHW N/A
- EPS
- ORIC N/A
- CHW N/A
- Revenue
- ORIC N/A
- CHW N/A
- Revenue This Year
- ORIC N/A
- CHW N/A
- Revenue Next Year
- ORIC N/A
- CHW N/A
- P/E Ratio
- ORIC N/A
- CHW N/A
- Revenue Growth
- ORIC N/A
- CHW N/A
- 52 Week Low
- ORIC $5.53
- CHW $5.07
- 52 Week High
- ORIC $14.67
- CHW $6.54
- Technical
- Relative Strength Index (RSI)
- ORIC 30.76
- CHW 33.81
- Support Level
- ORIC $5.78
- CHW $6.54
- Resistance Level
- ORIC $8.11
- CHW $6.70
- Average True Range (ATR)
- ORIC 0.52
- CHW 0.10
- MACD
- ORIC -0.13
- CHW -0.01
- Stochastic Oscillator
- ORIC 1.59
- CHW 25.39
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.